T/FIF, a New Plateau Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1232)	7/2/2002 10:04:14 PM
From: Miljenko Zuanic	Read Replies (1) of 2243

<<The last thing that we need is a gun shy or political FDA. I'm a big believer that FDA has done a good job in recent years. I agree with Peter, however. It will be interesting to see FDA/Corixa.>> Yes, FDA did rise bar on drug safety. But, is this unexpected? Should they rise only efficacy bar? Should they stick with the middle edge era bar for drug safety? First rule...safety! Second rule...more safety! Third rule...even more safety! Forth rule...efficacy! Didn't FDA recently approve two drugs with marginal efficacy? How was possible (in this honest word that we live in!) that FDA was tricked around with Rezulin? Miljenko PS: Blaming FDA and luck of commissioner is, for me, unexpected from any SI bio-freaks. Yes, like any government institutions FDA is full of bureaucrats. But, where are angels?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next